The new formulation features what Abbott calls a “triple care system,” anchored by a blend of nutrients aimed at supporting blood sugar control and metabolic health
Diversifying its portfolio to include late-phase antiviral agent
Leuprolide Acetate injection is indicated in the palliative treatment of advanced prostatic cancer
The investment in land is Rs. 19.85 crore
Dexlansoprazole delayed-release capsules are a proton pump inhibitor
The FDA is initiating removal of the boxed warnings following a comprehensive review of the scientific literature
The trial will evaluate safety endpoints including dose-limiting toxicities and adverse events
False positive rates?ranged from 0% to 41%, meaning some labs incorrectly identified bacteria that weren’t present in the sample
Cardiovascular disease (CVD) is the leading cause of death in the US and worldwide with over 82 million Americans living with CVD
LANXESS will highlight its commitment to combatting antimicrobial resistance by presenting science-based disinfection solutions
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
